Internal Limiting Membrane Peeling in Retinal Detachment Surgery

Launched by CENTRAL HOSPITAL, NANCY, FRANCE · Sep 9, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a surgical technique called internal limiting membrane (ILM) peeling during surgery for a type of eye condition known as retinal detachment, specifically when it’s complicated by grade B proliferative vitreoretinopathy (PVR). Retinal detachment occurs when the retina, the light-sensitive layer at the back of the eye, separates from its underlying supportive tissue, which can lead to vision loss. The trial aims to find out if peeling the internal limiting membrane can improve the success of the surgery in patients who have a specific type of retinal detachment where the central part of the retina (the macula) is not attached.

To be eligible for this study, participants must be adults over 18 years old who have a macula-off retinal detachment complicated by grade B PVR. Individuals with a history of previous retinal detachment, other eye surgeries (except cataract surgery), or certain eye diseases may not be able to join. Those who participate can expect to be randomly assigned to receive either the ILM peeling technique or standard care during their surgery. This trial is important because it seeks to improve surgical outcomes for patients facing this serious eye condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients older than 18 years old
• • With macula-off retinal detachment complicated by grade B proliferative vitreoretinopathy
• Exclusion Criteria:
• • Underage patients
• • History of retinal detachment
• • History of intraocular surgery (except for cataract surgery)
• • Traumatic retinal detachment
• • Macular hole-associated retinal detachment
• • Concurrent macular disease (diabetic maculopathy, age-related macular degeneration)